151 related articles for article (PubMed ID: 593468)
1. Prognostic significance of skin reactivity in patients with bronchogenic carcinoma grouped according to the TNM classification.
Plesnicar S; Rudolf Z; Lavrencic D
Neoplasma; 1977; 24(6):633-40. PubMed ID: 593468
[TBL] [Abstract][Full Text] [Related]
2. [Skin tests as immunologic parameters in cervical cancer].
Wagner G
Wien Klin Wochenschr; 1984 Jun; 96(12):467-73. PubMed ID: 6475075
[TBL] [Abstract][Full Text] [Related]
3. [Methyl heptine carbonate skin test in lung cancer--correlation with stage and prognosis].
Takanami I; Nakayama H; Ishihara T; Yanai N
Gan No Rinsho; 1984 Apr; 30(4):340-3. PubMed ID: 6727035
[TBL] [Abstract][Full Text] [Related]
4. [Skin reactions with ubiquitous multiple antigens as a test of survival in patients with inoperable bronchogenic carcinoma].
Giorgis GE; Oliaro A; Galietti F; Barberis S; Ardizzi A; Gallo E; Onoscuri E
Minerva Med; 1988 Jun; 79(6):447-9. PubMed ID: 3380311
[TBL] [Abstract][Full Text] [Related]
5. Immunoprofile studies for patients with bronchogenic carcinoma. I. Correlation of pretherapy studies with survival.
Liebler GA; Concannon JP; Magovern GJ; Dalbow MH; Hodgson SE
J Thorac Cardiovasc Surg; 1977 Oct; 74(4):506-18. PubMed ID: 302883
[TBL] [Abstract][Full Text] [Related]
6. Sequential evaluation of DNCB reactivity in patients with primary lung cancer. Correlation with prognosis.
Inoue H; Ishihara T; Kobayashi K; Fukai S
J Thorac Cardiovasc Surg; 1978 Oct; 76(4):479-82. PubMed ID: 703354
[TBL] [Abstract][Full Text] [Related]
7. [Delayed skin reaction in a group of 400 hospital patients: control study (author's transl)].
Orriols R; Morell F; Fité E; Ruiz J; Tornos C; Sanz R; Morera J
Med Clin (Barc); 1981 Oct; 77(6):240-2. PubMed ID: 7321638
[TBL] [Abstract][Full Text] [Related]
8. Factors of delayed hypersensitity in pulmonary tuberculosis.
Malaviya AN; Sehgal KL; Kumar R; Dingley HB
Am Rev Respir Dis; 1975 Jul; 112(1):49-52. PubMed ID: 1080026
[TBL] [Abstract][Full Text] [Related]
9. [Relationships between clinico-therapeutic parameters and immunological status in patients with lung cancer].
Roviaro GC; Varoli F; Sartori F; Calabrò F; Bortolotti F; Tremolada F; Fattovich G; Cecchetto A; Paruzzolo P
Minerva Med; 1980 Jun; 71(25):1757-67. PubMed ID: 6997779
[TBL] [Abstract][Full Text] [Related]
10. Delayed cutaneous hypersensitivity reactions to tumor cell antigens and to nonspecific antigens. Prognostic significance in patients with lung cancer.
Wells SA; Burdick JF; Joseph WL; Christiansen CL; Wolfe WG; Adkins PC
J Thorac Cardiovasc Surg; 1973 Oct; 66(4):557-62. PubMed ID: 4755446
[No Abstract] [Full Text] [Related]
11. Delayed hypersensitivity reactions in patients with carcinoma of the colon and rectum.
Rao B; Wanebo HJ; Pinsky C; Stearns M; Oettgen HF
Surg Gynecol Obstet; 1977 May; 144(5):677-81. PubMed ID: 850850
[TBL] [Abstract][Full Text] [Related]
12. [Comparative survival study between the old and new bronchogenic carcinoma classification].
Martínez-Somolinos S; Rubio-Garay MM; Mármol-Cazas EE; Baldó-Padró X; Penagos-Tafurt JC; Sebastián-Quetglás F; García-Gil Mdel M
Cir Esp; 2011 Oct; 89(8):539-45. PubMed ID: 21458781
[TBL] [Abstract][Full Text] [Related]
13. Enhanced delayed hypersensitivity skin test reactivity with serial testing in healthy volunteers.
Keystone EC; Demerieux P; Gladman D; Poplonski L; Piper S; Buchanan R
Clin Exp Immunol; 1980 Apr; 40(1):202-5. PubMed ID: 6993077
[TBL] [Abstract][Full Text] [Related]
14. [Role of immune skin reactions in progressive lung cancer during the administration of OK-432--relation to reactions to DNCB, PPD and Su-PS].
Katada H; Nishikawa K; Yoneda T; Kitamura H; Nakajima A; Mikami R
Gan To Kagaku Ryoho; 1987 Jan; 14(1):61-70. PubMed ID: 3026256
[TBL] [Abstract][Full Text] [Related]
15. Value of delayed hypersensitivity index in patients with malignancy.
Morris DL
Ann Allergy; 1977 Mar; 38(3):182-4. PubMed ID: 842905
[TBL] [Abstract][Full Text] [Related]
16. DNCB and PPD skin tests and prognosis in 152 patients with breast cancer. A prospective 2-year follow-up.
Munzarová M; Kovarík J; Hlávková J; Popelínský L; Lauerová L
Neoplasma; 1985; 32(1):45-50. PubMed ID: 3982560
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the effects of malnutrition and malaria on skin reactions in delayed hypersensitivity to tuberculin, varidase and phytohemagglutinin].
Monjour L; Palminteri R; Froment A; Daniel-Ribeiro C; Alfred C; Gouba E; Gentilini M
Pathol Biol (Paris); 1983 Oct; 31(8):703-6. PubMed ID: 6359030
[TBL] [Abstract][Full Text] [Related]
18. [Classification of the disease and pathologic type of bronchogenic carcinoma (III) (author's transl)].
López Encuentra A; Martínez González del Río J; Vallejo Galvete J
Med Clin (Barc); 1979 Jun; 73(2):49-54. PubMed ID: 481002
[TBL] [Abstract][Full Text] [Related]
19. Skin tests with autologous cholesteryl hemisuccinate-treated tumor cells, DNCB and PPD and their relationship to prognosis in malignant melanoma patients.
Munzarová M; Mechl Z; Kovarík J; Kolcová V
Neoplasma; 1988; 35(2):229-34. PubMed ID: 3374711
[TBL] [Abstract][Full Text] [Related]
20. Delayed cutaneous hypersensitivity and peripheral lymphocyte counts in patients with advanced cancer.
Lee YT; Sparks FC; Eilber FR; Morton DL
Cancer; 1975 Mar; 35(3):748-55. PubMed ID: 1111942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
